posted on 2025-11-18, 13:38authored byIsabel Mercedes Everard
This research used patient-derived tumour models to investigate why some prostate cancers do not respond to the targeted radioligand therapy Lutetium-177-PSMA. It aimed to identify tumour-specific factors influencing treatment effectiveness and resistance, providing insights into how to optimise this therapy and improve outcomes for patients with advanced prostate cancer.
History
Principal supervisor
Gail Petuna Risbridger
Additional supervisor 1
Renea Taylor
Additional supervisor 2
Laura Porter
Additional supervisor 3
Natalie Lister
Year of Award
2025
Department, School or Centre
Anatomy and Developmental Biology
Campus location
Australia
Course
Doctor of Philosophy
Degree Type
DOCTORATE
Faculty
Faculty of Medicine, Nursing and Health Sciences
Rights Statement
The author retains copyright of this thesis. It must only be used for personal non-commercial research, education and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission. For further terms use the In Copyright link under the License field.